Corey Davis
Stock Analyst at HC Wainwright & Co.
(3.00)
# 1,508
Out of 5,045 analysts
17
Total ratings
75%
Success rate
25.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corey Davis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Reiterates: Neutral | $480 → $390 | $59.63 | +554.03% | 5 | May 12, 2020 | |
| SCYX SCYNEXIS | Assumes: Buy | $50 | $0.69 | +7,179.08% | 3 | May 7, 2018 | |
| VTVT vTv Therapeutics | Downgrades: Neutral | $560 → $40 | $21.07 | +89.84% | 2 | Apr 10, 2018 | |
| LPCN Lipocine | Initiates: Buy | $170 | $2.69 | +6,219.70% | 1 | Mar 29, 2018 | |
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $20 | $5.41 | +269.69% | 2 | Jan 19, 2018 | |
| PCRX Pacira BioSciences | Initiates: Buy | $50 | $21.01 | +137.98% | 3 | Jan 19, 2018 | |
| JAZZ Jazz Pharmaceuticals | Initiates: Neutral | $144 | $135.73 | +6.09% | 1 | Aug 25, 2017 |
Nektar Therapeutics
May 12, 2020
Reiterates: Neutral
Price Target: $480 → $390
Current: $59.63
Upside: +554.03%
SCYNEXIS
May 7, 2018
Assumes: Buy
Price Target: $50
Current: $0.69
Upside: +7,179.08%
vTv Therapeutics
Apr 10, 2018
Downgrades: Neutral
Price Target: $560 → $40
Current: $21.07
Upside: +89.84%
Lipocine
Mar 29, 2018
Initiates: Buy
Price Target: $170
Current: $2.69
Upside: +6,219.70%
Vanda Pharmaceuticals
Jan 19, 2018
Initiates: Buy
Price Target: $20
Current: $5.41
Upside: +269.69%
Pacira BioSciences
Jan 19, 2018
Initiates: Buy
Price Target: $50
Current: $21.01
Upside: +137.98%
Jazz Pharmaceuticals
Aug 25, 2017
Initiates: Neutral
Price Target: $144
Current: $135.73
Upside: +6.09%